Formulations for IL-11
AssigneeGenetics Institute, Inc.
InventorNicholas W. Warne
Life of this patent
Estimating the term…
Abstract
The present invention provides novel formulations comprising IL-11 and glycine. Also provided are compositions, both liquid and lyophilized, comprising IL-11 and glycine and optionally, a buffering agent such as histidine and phosphate.
Claims20
A composition comprising IL-11 and glycine.
A composition comprising IL-11, glycine, and a buffering agent.
A composition comprising about 5.0 mg/mL IL-11, 300 mM glycine, and 10 mM sodium phosphate.
A composition comprising about 5.0 mg/mL IL-11, 300 mM glycine, and 20 mM histidine.
A composition comprising des-Pro-IL-11 and glycine.
A composition comprising about 5.0 mg/mL des-Pro-IL-11 and 300 mM glycine.
Dependencies are inferred from the claim text.